Multicenter Validation of a Risk Prediction Model for MDRGNB Infection

ConditionInfection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

About this trial

This prospective multicenter validation study aimed to evaluate the predictive performance of a previously developed model for MDRGNB infection in ICU patients.

Eligibility criteria

Qualifiers

Age ≥18 years;

ICU stay ≥48 hours;

At least one clinical microbiological specimen collected and submitted for testing within 48 hours of ICU admission, with the first submission time designated as the index time;

Core predictive variables of the model extractable from electronic medical records or laboratory information systems.

Disqualifiers

For patients with multiple ICU admissions, only the first ICU stay was retained;

Missing or indeterminate primary outcome;

Missing key predictive variables that could not be handled according to prespecified rules.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group

Sponsors and collaborators